L&G Pharma Breakthrough UCITS ETF
ETLI.DE
#3168
ETF rank
$19.83 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
$14.42
Share price
-0.85%
Change (1 day)
35.01%
Change (1 year)

Expense ratio and fees for L&G Pharma Breakthrough UCITS ETF (ETLI.DE)

Total Expense Ratio

Total Expense Ratio as of November 2025: 0.49%

ter

ter as of June 2026: 0.49%